Shareholders meeting

September 05, 2026 To, To, Listing / Compliance Department Listing / Compliance Department BSE LTD National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, Dalal Street G Block Bandra-Kurla Complex, Mumbai- 400 001 Bandra (E), Mumbai- 400 051. SCRIP CODE – 540145 SYMBOL- VALIANTORG Sub: Notice of the 21st Annual General Meeting of the Members and Annual Report of the Company for the Financial Year 2025-26 Ref: Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (the “Listing Regulations”) Dear Sir / Madam, Please find enclosed herewith the Notice of the 21st Annual General Meeting (“AGM”) of the Company scheduled to be held on Tuesday, September 29, 2026 at 11:30 A.M. (IST) through Video Conferencing (VC) / Other Audio-Visual Means (OAVM) along with the Annual Report of the Company for the Financial Year 2025-26. The AGM will be held without the physical presence of the Members at a common venue. In terms of the provisions of applicable laws and circulars, the Notice of AGM and Annual Report covering Annual Financial Statements for the FY 2025-26, are being sent through email only, to all those members whose email address(es) are registered with the Company/ RTA/ Depository Participant(s)/Depositories. The Notice, inter-alia, covers the detailed instructions for e-voting, attendance at the AGM through VC and registration of email address(es) by the members. Further, the Company has also initiated sending letters containing the web-link of the Annual Report for FY 2025- 26 to the Shareholders whose e-mail addresses are not registered with the Company, or with MUFG Intime India Private Limited (The Registrar and Share Transfer Agent), or with their respective Depository Participants. The Notice of 21st AGM of the Company along with Annual Report for the Financial Year 2025- 26 is available on the website of the Company at www.valiantorganics.com. Kindly take the same on your record. Thanking You, Yours Faithfully, For Valiant Organics Limited Kaustubh Kulkarni Company Secretary ICSI M. No: A52980 Encl.: a/a Regd. Office:109, Udyog Kshetra, 1st Floor, Mulund Goregaon Link Rd, Mulund (W), Mumbai 400 080, Maharashtra, India. Corporate Office: 701-A, 7th Floor, Tower-B, Embassy 247, L.B.S. Road, Vikhroli (W), Mumbai - 400 083, Maharashtra, India. +91 22 6797 6683 • info@valiantorganics.com • www.valiantorganics.com CIN NO.: L24230MH2005PLC151348 Annual Report 2025-26 Sharper Chemistry. Stronger Performance. Contents Corporate Overview 01 Sharper Chemistry. Stronger Performance. 02 Company Overview 06 Journey 08 Process and Product Portfolio 12 Managing Director’s Message 16 Operating Context 18 Strategies 20 Performance Highlights 22 Environmental, Social and Governance 24 Board of Directors 26 Corporate Information Forward-looking statement Statutory Reports This document contains statements 27 Management Discussion about expected future events and and Analysis financial and operating results of Valiant 36 Directors’ Report Organics Limited, which are forward- looking. By their nature, forward-looking 64 Report on Corporate Governance statements require the Company to make assumptions and are subject to inherent risks and uncertainties. There is a significant risk that the assumptions, Financial Statements predictions and other forward-looking 92 Standalone Financial Statements statements will not prove to be accurate. Readers are cautioned not to place 169 Consolidated Financial Statements undue reliance on forward-looking statements as a number of factors could cause assumptions, actual future results and events to differ materially from Annual General Meeting those expressed in the forward-looking 245 Notice statements. Accordingly, this document is subject to the disclaimer and qualified in its entirety by the assumptions, qualifications and risk factors referred to in the Management’s Discussion and See the report online at Analysis of the Valiant Organics Limited www.valiantorganics.com Annual Report 2025-26. Sharper Chemistry. Stronger Performance. Every chemical transformation depends on precision. The right balance, the right conditions and the right control can change the outcome entirely. FY 2025-26 was a year of such recalibration for Valiant Organics. We sharpened our decisions across costs, capacity utilisation, procurement, product mix and process efficiency. Attention returned firmly to the core, with each operating lever examined for the value it could release and the resilience it could build. The results gathered strength as the year progressed. Better yields and higher throughput improved cost absorption. Hydrogenation gained momentum, chlorination and ammonolysis remained steady, and This is where the pharmaceutical intermediates business assumed SHARPER greater strategic relevance. PAP returned to focus, strengthening our presence in a more stable and higher- CHEMISTRY value segment. is translating into This was a recovery built from within. Margins expanded, profitability returned and the final quarter STRONGER reflected the strongest momentum of the year. More importantly, the improvement was supported by PERFORMANCE. structural actions that made the business leaner, more disciplined and better prepared for growth. Valiant Organics now moves ahead with greater control over its operating rhythm, clearer growth priorities and renewed confidence in the strength of its core. 02 | VALIANT ORGANICS LIMITED | ANNUAL REPORT 2025-26 Company Overview Built on Specialised Chemistry Valiant Organics Limited is a Mumbai- As part of the Aarti Group, we benefit from backward integration, deep headquartered manufacturer of speciality process knowledge and established chemicals, established in 1984 by first- manufacturing capabilities. Our generation technocrats. We have developed in-house research and quality expertise across chlorination, hydrogenation, capabilities, supported by advanced laboratory infrastructure and an ammonolysis, acetylation, sulphonation, experienced team of chemists, help methoxylation and other specialised us maintain international standards chemistries. Our portfolio serves diverse and continually refine our processes. applications across dyes pigments, This focus on precision, efficiency and reliability enables us to respond agrochemicals, pharmaceuticals, speciality to evolving customer requirements chemicals and with a focus on products that and strengthen relationships across support domestic import substitution. domestic and international markets. CORPORATE OVERVIEW | COMPANY OVERVIEW | 03 Our leadership positions One of the One of the One of the largest chlorophenol largest leading manufacturers derivatives domestic PNA of Benzene derivatives manufacturers globally manufacturers products One of the One of the few commercial players largest in Ortho Anisidine and domestic PAP Para Anisidine manufacturers Operational highlights 6 5 80,000+ TPA Manufacturing units Zero Liquid Total Production Capacity across 5 Locations Discharge plants 900+ Crisil A-/ Stable (Outlook revised from Employees ‘Negative’) II Crisil A2 + (Re-affirmed) Credit ratings OHSAS 18001: 2007, ISO 14001: 2015 and ISO 9001:2015 Key Certifications 04 | VALIANT ORGANICS LIMITED | ANNUAL REPORT 2025-26 Key strengths Diversified business model Deep domain expertise A broad product portfolio and We bring extensive process knowledge customer base across industries and across multiple chemistries, supported by geographies help reduce product, a technocrat-led management team with sector and market concentration risks. over five decades of collective experience Integrated operations Reliable supply chain Our multi-purpose, backward and forward A well-established supplier network integrated facilities enable flexible supports the consistent availability production across products, specifications, of quality raw materials across our batch sizes and delivery schedules [Showing first 8,000 characters — download PDF for full document]